Hannah Joseph Hospital Limited
IPO Details
Subscription
Lot Distribution
Reservation
Company Fin.
₹0(0.00%)
Premium (ELP)
Following its successful public offering, Hannah Joseph Hospital Limited's made its market debut on Feb 02, 2026 and is now actively traded on the BSEplatform. The IPO mobilized 60,00,000 Shares in total capital, including 60,00,000 Shares in primary equity infusion.
The offering was structured with a price band of ₹67 to ₹70 and minimum investment lots of 1500 shares. Investor participation during the subscription window from Jan 22, 2026 to Jan 28, 2026 demonstrated market confidence in the company's prospects.
The allotment process concluded on Jan 29, 2026, allocating shares to successful bidders. The listing represents the culmination of the IPO process, transitioning the company to publicly traded status with enhanced transparency and governance standards.
Investors can bid starting from the minimum lot size specified for this IPO, and only in multiples of that lot size. The table below shows the minimum and maximum investment for retail investors and HNIs in terms of lots, quantity, and amount.
Incorporated in 2011, Hannah Joseph Hospital Limited is a multi-specialty healthcare provider based in Madurai, operating from a 2-acre campus with modern infrastructure including central air-conditioning and water heating systems and a total capacity of 150 beds. The hospital focuses on delivering quality and affordable healthcare services across key specialties such as neurosciences (neurology and neurosurgery), cardio sciences (cardiology), trauma care (orthopaedics and oral & maxillofacial surgery), and psychiatry, while aligning medical expertise with patient-centric care. As of November 30, 2025, the company employs 364 professionals supporting its clinical and operational activities.
Note : "Calculations for ‘Shares Offered’ and ‘Total Amount’ are based on the highest price in the issue price band."
- Strong Neurosciences Expertise: Well-established capabilities in neurology and neurosurgery.
- Advanced Cardiac Care: Comprehensive cardiology services supporting critical treatments.
- Specialised Trauma & Orthopaedic Care: Integrated trauma management improves emergency response and patient outcomes.
- Radiation Oncology Execution Risk: Delays in equipment procurement, approvals, or commissioning may affect timelines and costs.
- Regulatory Approval Dependency: Failure to obtain or renew required licenses could disrupt operations.
- Project Implementation Uncertainty: The new centre may face delays or budget overruns.
- Mosesjoseph Arunkumar
- Fenn Kavitha Fenn Arunkumar
- Arunkumar Nalina
- Noyel Arunkumar
Hannah Joseph Hospital Limited
Bigshare Services Private Limited